🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study proposes to evaluate the safety, tolerability, and efficacy of PD...
Status
Terminated
Location
Mount Sinai School Of Medicine/Mount Sinai Medical Center
Start Date
2013-03-15
Trial ID
NCT01732211
Treatments Being Tested
This study is a multi-center, randomized, double-blind, placebo-controlled ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-09-13
Trial ID
NCT06547333
This study will be conducted to evaluate the efficacy of lecanemab in parti...
Status
Active Not Recruiting
Location
Banner Alzheimer's Institute- Clinical Trials Department
Start Date
2019-03-27
Trial ID
NCT03887455
Treatments Being Tested
This study will evaluate the percentage change from baseline in weight afte...
Status
Completed
Location
Handan First Hospital
Start Date
2024-08-14
Trial ID
NCT07020884
Treatments Being Tested
This is a multi-center, randomized, double blind, placebo-controlled study ...
Status
Unknown
Location
The First Affiliated Hospital of Guangzhou Medical University
Start Date
2022-07-19
Trial ID
NCT06642961
Treatments Being Tested
The purpose of the study is to learn about the safety of MK-2225, including...
Status
Completed
Location
Clinical Pharmacology of Miami (Site 0002)
Start Date
2023-11-21
Trial ID
NCT06643390
This is a multi-center, randomized, double blind, placebo-controlled phase ...
Status
Completed
Location
Peking University People's hospital
Start Date
2022-04-22
Trial ID
NCT05265923
Primary Objective: To evaluate the effect of alirocumab (SAR236553/REGN727...
Status
Completed
Location
Investigational Site Number 840616
Start Date
2011-01
Trial ID
NCT01288469
Treatments Being Tested
This study will evaluate the effect and safety of 611 in patients with Chro...
Status
Active Not Recruiting
Location
Site 01
Start Date
2024-11-22
Trial ID
NCT06639295
Primary objective: \- to evaluate the efficacy of Sarilumab in participant...
Status
Completed
Location
Investigational Site Number 840006
Start Date
2010-02
Trial ID
NCT01061723